Skip to content
★ Sign in to follow
AA

Alfred Akirov

Executive
Protalix BioTherapeutics, Inc.
Total declarations
18
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (18 ops.)
€685k

Latest filing published 16 Aug 2013 for Protalix BioTherapeutics, Inc., €381k.

Insider track record

Disclosed buys
0
Disclosed sells
18
Signal history

No signal scores available.

Alfred Akirov: trading record in brief

Alfred Akirov discloses dealings in Protalix BioTherapeutics, Inc. to SEC (Form 4). In total, 18 filings cover trades dated from 6 March 2013 to 15 August 2013.

Sales make up the whole of the open-market record (18 sales, €685k).

The newest entry dates from 16 August 2013: an open-market sale of €381k, in Protalix BioTherapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Alfred Akirov

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total

18 of 18 declarations